Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance

Sohier P., Raymond JH., Aktary Z., Zidi N., Araktingi L., Charoenchon N., Pisibon C., Caberia S., Pasmant E., Macagno N., Delmas V., Gaudy-Marqueste C., Steingrimsson E., Ballotti R., Petit V., Larue L.